Philip Reardon

Philip Reardon, PhD, is an accomplished medical writer with extensive experience in research and communication across various domains. Currently, as a Medical Writer at Envision Pharma Group since January 2021, Philip previously served as an Associate Medical Writer. Philip's tenure as a JSPS Postdoctoral Fellow at Nagoya Institute of Technology from November 2017 to November 2019 is marked by successful collaboration that secured JP¥10 million in funding for developing nanosized antibacterial materials. As a Postdoctoral Research Associate at University College London from 2014 to 2017, Philip demonstrated strong information management skills through the analysis of clinical data, resulting in three international presentations and four publications. Philip holds a PhD in Biomaterials Engineering, an MS in Chemical Engineering, and a BS in Chemistry, all from prestigious institutions.